Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/106693
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-02-22T06:59:58Z | - |
dc.date.available | 2023-02-22T06:59:58Z | - |
dc.date.issued | 2022 | - |
dc.identifier.citation | Savona-Ventura, Y. (2022). Addressing long-term use of benzodiazepines (Doctoral dissertation). | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/106693 | - |
dc.description | Pharm.D.(Melit.) | en_GB |
dc.description.abstract | Even though several psychiatric organisations advise against the use of benzodiazepines, they are still considered as one of the major class of drugs which are continuously misused and overprescribed. This is especially unfavourable in the older population. These concerns support strategies for deprescribing and ensuring safe and rational use. Such a scenario brought about the research question namely: what strategies could be adopted to address misuse of benzodiazepines. The aim was to understand local trends of benzodiazepine use and propose strategies and address appropriate use of this class of drugs. The objectives of this study were to obtain evidence of status of use of benzodiazepines and to develop frameworks which support prescribers, pharmacists and patients in addressing the concerns of over-use. The methodology was intended to identify barriers that a prescriber encounters in deprescribing processes. Data available within the National Health System on benzodiazepine usage was analysed and factors including age, gender, medication, dose and regimen were noted. A data collection tool was developed and patients visiting community pharmacies and filling benzodiazepine prescriptions were interviewed on use of benzodiazepines. A focus group made up of medical experts in the field was set-up to discuss the evidenced based data using analysed trends. Discussions were held regarding the potential irrational prescribing of benzodiazepines, the barriers prescribers face, access to the medication, and regulatory challenges. Within the National Health System, 7,683 patients were on a long-term benzodiazepine and approximately 7 million benzodiazepine tablets were consumed per year. The most prescribed medicines were lorazepam (n=2,449,684), followed by bromazepam (n=2,004,240) and diazepam (n=1,174,912). These results were also reflected within the community pharmacies through the completion of the developed data tool. In the study population (n=113), statistical significant differences between duration of treatment were observed (p<0.05) for benzodiazepine prescribed, age groups, diagnosis, original prescriber, and dose, as well as diagnosis versus benzodiazepine prescribed. The focus group panel identified patient assuming doctor’s approval, patient not aware of adverse effects and alternatives, benzodiazepine are highly effective and are hard to replace, patient feels reliant and fears return of symptoms, deprescribing is time-consuming and demanding, and devolving of responsibility as the most significant enablers and barriers when deprescribing benzodiazepines. As primary dispensers, pharmacists are in the optimal role to campaign and raise awareness about the adverse effects associated with benzodiazepines. Through the focus group meetings, information was gathered to construct and propose a plan which would serve as a guideline for prescribers to deprescribe benzodiazepines and to prescribe benzodiazepines long-term in a safer way. This plan could also serve as a guide for other healthcare workers to engage patients and support deprescribing. A multidisciplinary approach, contributes towards better implementation and outcomes. | en_GB |
dc.language.iso | en | en_GB |
dc.rights | info:eu-repo/semantics/restrictedAccess | en_GB |
dc.subject | Benzodiazepines | en_GB |
dc.subject | Benzodiazepines -- Physiological effect | en_GB |
dc.subject | Benzodiazepine abuse -- Malta | en_GB |
dc.subject | Older people -- Medical care | en_GB |
dc.subject | Drug utilization -- Malta | en_GB |
dc.title | Addressing long-term use of benzodiazepines | en_GB |
dc.type | doctoralThesis | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.publisher.institution | University of Malta | en_GB |
dc.publisher.department | Faculty of Medicine and Surgery. Department of Pharmacy | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.contributor.creator | Savona-Ventura, Yvonne (2022) | - |
Appears in Collections: | Dissertations - FacM&S - 2022 Dissertations - FacM&SPha - 2022 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2227MDSPHR663700003473_1.PDF | 4.48 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.